Westtown Optical Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 609 W Clinton St, Ithaca, NY 14850 Phone: 607-272-7775 Fax: 607-319-5178 |
Dr. Reena Patro, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 106 Dryden Rd, Ithaca, NY 14850 Phone: 607-273-1234 |
Dr. Edward George Bryant Iv, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1284 Dryden Road, Ithaca, NY 14850 Phone: 607-257-1066 Fax: 607-257-1378 |
Frederick A. Wood Optometrist - Corneal and Contact Management Medicare: Medicare Enrolled Practice Location: 134 The Commons, Ithaca, NY 14850 Phone: 607-273-4231 Fax: 607-273-4654 |
Dr. Frederick A Wood, OD Optometrist - Corneal and Contact Management Medicare: May Accept Medicare Assignments Practice Location: 134 The Commons, Ithaca, NY 14850 Phone: 607-273-4231 Fax: 607-273-4654 |
Clarity Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 1284 Dryden Road, Ithaca, NY 14850 Phone: 607-257-1066 Fax: 607-257-1378 |
Dr. Paul T Kempkes, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 40 Catherwood Rd, Sterling Optical, Pyramid Mall, Ithaca, NY 14850 Phone: 607-257-2333 Fax: 607-257-1763 |
Kayla M Whelan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1284 Dryden Rd, Ithaca, NY 14850 Phone: 607-257-1066 |
Mary Katherine Conroy, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 100 Uptown Rd, Ithaca, NY 14850 Phone: 607-257-5599 |
News Archive
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
Two new studies led by UT Southwestern scientists outline how individual cells maintain their internal clocks, driven both through heritable and random means.
A team of Penn State University scientists has invented a new system that uses magnetism to purify hybrid nanoparticles - structures that are composed of two or more kinds of materials in an extremely small particle that is visible only with an electron microscope.
Even during months of stubborn unemployment, the health care industry has provided a solid underpinning, reliably adding jobs in an otherwise dismal environment.
Ceram, the international materials technology company, has launched a Regulatory Approval Service, designed to help hydroxyapatite users and manufacturers in the medical device industry gain FDA acceptance of their 510(k) submission.
› Verified 5 days ago